Quick Answer
Emergent BioSolutions Inc. reported Total Revenue of $742.90 million for the year ending 2025.
- Emergent BioSolutions Inc. showed a decrease of -28.8% in Total Revenue from 2024 to 2025.
- This data is from Emergent BioSolutions Inc.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2016 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $116.90 million | Q2 2017: $100.80 million | Q3 2017: $149.40 million | Q4 2017: $193.80 million | Q1 2018: $117.80 million | Q2 2018: $220.20 million | Q3 2018: $173.70 million | Q4 2018: $270.70 million | Q1 2019: $190.60 million | Q2 2019: $243.20 million | Q3 2019: $311.80 million | Q4 2019: $360.40 million | Q1 2020: $192.50 million | Q2 2020: $394.70 million | Q3 2020: $385.20 million | Q3 2020: $385.20 million | Q4 2020: $583.00 million | Q1 2021: $343.00 million | Q1 2021: $343.00 million | Q2 2021: $397.50 million | Q2 2021: $397.50 million | Q3 2021: $329.00 million | Q1 2022: $304.80 million | Q2 2022: $242.60 million | Q3 2022: $239.90 million | Q1 2023: $164.30 million | Q2 2023: $337.90 million | Q3 2023: $270.50 million | Q1 2024: $300.40 million | Q1 2024: $300.40 million | Q2 2024: $254.70 million | Q2 2024: $254.70 million | Q3 2024: $293.80 million | Q3 2024: $293.80 million | Q1 2025: $222.20 million | Q2 2025: $140.90 million | Q3 2025: $231.10 million.
- Over the full 14 years of available data (2016 to 2025), Emergent BioSolutions Inc.'s Total Revenue has grown by 52.0%.
- Historical annual values: Fiscal year 2025: $742.90 million | Fiscal year 2024: $1.04 billion | Fiscal year 2024: $1.04 billion | Fiscal year 2023: $1.05 billion | Fiscal year 2023: $1.05 billion | Fiscal year 2022: $1.12 billion | Fiscal year 2021: $1.77 billion | Fiscal year 2020: $1.56 billion | Fiscal year 2020: $1.56 billion | Fiscal year 2019: $1.11 billion | Fiscal year 2019: $1.11 billion | Fiscal year 2018: $782.40 million | Fiscal year 2017: $560.90 million | Fiscal year 2016: $488.80 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: